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Fast or slow infusion rate for ajmaline challenge in suspicion of Bru-
gada Syndrome?
Elise Dassonvalle-Arnalsteen JS Hermida, I Six, S Quenum, M Kubala, G
Jarry
CHU Amiens sud, cardiologie A, Amiens, France
Na channel blockade challenge is the cornerstone of the diagnosis of Bru-
gada Syndrome (BS). Since the second conference of consensus, the infusion
rate of ajmaline during Na channel blockade challenge consist in 1mg/kg
during 5 minutes. In clinical practice, infusion rate of ajmaline differs between
centers; in fact, there’s no data that compare two infusion rates during ajma-
line challenge. Fast infusion rate is used in centers having experience of ajma-
line in the diagnostic management of conductive diseases. Slow infusion rate
is advocated by others owing to a risk of pro arrhythmia.
Aim of the study: The aim of the study is to compare the results and the
safety of a fast and of a slow infusion rate during ajmaline challenge in suspi-
cion of BS.
Methods: 32 patients (M=26, F=6; 41±12 years) who had an ajmaline
challenge according to a type 2 (69%) or 3 ECG (31%), mainly for a familial
screening (37,5%), were prospectively included. They underwent 2 ajmaline
challenges on separate days. Ajmaline (1mg/kg) was infused either during a
rate of 1mg/s or during 10 minutes. Primary end point was the result of the
challenge. Secondary end points were the occurrence of ventricular arrhythmia
and the magnitude of ECG modifications.
Results: No differences were observed between the two protocols as
regards positive and negative results. No Ventricular Tachycardia occurred.
No differences were observed on the occurrence of isolated ventricular ectopic
beats (p=.5). Heart rate increased more during slow test (15.5% vs 11%,
p=.04). Variations of corrected QT, PR interval, QRS duration and J wave ele-
vation were similar in both challenges.
Conclusion: Fast and slow infusion rate of ajmaline afforded the same
results. Ventricular ectopic beats occurred with the same incidence in both
tests. In clinical practice, we could reduce the time procedure of the ajmaline
challenge, as concerns type 2 or 3 Brugada Syndrome ECG, particularly for a
familial screening.
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RV Septal Pacing in Clinical Practice: Long-Term Results of the
NOVUS Septal Study
Jean Pierre Cebron (1), Daniel Gras (1), Marc Burban (1), Marc Hero (2)
(1) Nouvelles Cliniques Nantaises, Cardiologie, Nantes, France – (2)
Medtronic France, Boulogne Billancourt, France
Right ventricular (RV) apical pacing is known to have a deleterious effect
on hemodynamics, leading to consider the ventricular septum as a better alter-
native. The Novus Septal Study, aimed to evaluate the long-term performance
of the Novus 5076 RV lead (Medtronic-USA), implanted at the RV septum in
routine practice.
Methods: Implantation of the RV septum lead was performed in 371
consecutive patients (Male 64%, average age 77 +/- 8 years). Pacing indi-
cation was advanced AVB (70%), SD (27%) and drug refractory heart
failure in 3%. A single- dual- or triple-chamber pacemaker device was
used in 17%, 80%, and 3% of cases respectively. Appropriate RV Septal
lead positioning was validated by using per-operative LAO 30° projection
(92%) and/or negative Q wave deflection in Lead I (67%). Time duration
of RV lead placement was recorded at implant. Electrical RV lead param-
eters, including lead impedance, pacing thresholds and R wave sensing,
were systematically monitored at 1 and 5 min after implantation and at 3
month follow up (FU).
Results: Long-term RV septal pacing could not be evaluated in 15 patients
(4%), due to failure in positioning the RV lead at the septum in 10 (finally
implanted at the apex), to lead dislodgement in 3, hight threshold in 1 and low
sensing in 1, as recorded at 3 month FU. The remaining patients were subdi-
vided into 3 subgroups, based on the methods selected to validate RV septal
lead placement with the results as shown in table 1.
* decreasing of impedance at 3 month FU for group 1 and 2 (p<0.001)
** increasing of the time duration for the group 3 vs 1 and 2.
Conclusions: Long-term reliable RV septal pacing could be achieved in
routine practice in the vast majority of patients (96%) using standard pacing
or CRT indications. RV septal implantation duration may be longer using
ECG criteria as compared to LAO 30° projection. RV Septal lead pacing and
sensing thresholds remained stable over time, while lead impedance could
decrease over time. 
Nb LAO 30° Neg Q Lead I threshold sensing impedance time duration (mn)
235 yes yes 1 mn 0.7 +/– 0.5 11.0 +/– 5.6 822 +/– 245 2’ 00
5 mn 0.6 +/– 0.4 11.3 +/– 5.9 788 +/– 218
3 month 0.5 +/– 0.2 11.5 +/– 5.3 570 +/– 167*
106 yes no 1 mn 0.6 +/– 0.3 10.3 +/– 5.6 793 +/– 190 1’ 58
5 mn 0.5 +/– 0.2 11.0 +/– 5.2 767 +/– 190
3 month 0.5 +/– 0.4 12.1 +/– 5.9 595 +/– 152*
13 no yes 1 mn 0.8 +/– 0.5 9.7 +/– 5.2 830 +/– 158 6’ 40**
5 mn 0.6 +/– 0.3 9.6 +/– 5.0 779 +/– 160
3 month 0.5 +/– 0.1 12.0 +/– 4.6 713 +/– 155
